COMPASS THERAPEUTICS, INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-25.2M | $-18.3M | $-14.3M | $-19.9M | $-16.6M | $-10.5M | $-13.1M | $-10.8M |
| Depreciation & Amortization | — | $15.0K | — | — | $140.0K | — | — | $154.0K |
| Depreciation | — | $15.0K | — | — | $140.0K | — | — | $200.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | $5.1M | — | — | $2.5M | — | — | $2.0M |
| Net Cash from Operating Activities | $-14.7M | $-17.3M | $-10.8M | $-11.8M | $-13.2M | $-11.1M | $-10.8M | $-13.9M |
| Investing Activities | ||||||||
| Capital Expenditures | $176.0K | $82.0K | $7.0K | $0 | $18.0K | $44.0K | $0 | $0 |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $38.4M | — | — | $11.6M | — | — | $-4.1M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $3.4M | — | — | $-815.0K | — | — | $17.4M |
| Net Change in Cash | — | $24.5M | — | — | $-2.4M | — | — | $-554.0K |
| Free Cash Flow | $-14.9M | $-17.4M | $-10.9M | $-11.8M | $-13.2M | $-11.1M | $-10.8M | $-13.9M |